Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)

Key facts

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Principal Investigator

Martine MAUGET FAYSSE

Fondation Ophtalmologique A. de Rothschild

Enrollment

7 enrolled

Eligibility

18 years · All sexes

Timeline

2015 – 2018

Study locations (1)

• Fondation Ophtalmologique A. de Rotchschild, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →